Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

STERIS Now Expects FY24 As Reported Revenue To Increase 10-11%, Up From Previous Expectations Of 9-10%; Revises Adjusted EPS Outlook From $8.60-$8.80 To $8.60-$8.70 (Est $8.67)

Author: Benzinga Newsdesk | February 07, 2024 05:37pm

Adjusted earnings per diluted share revised due primarily to a shift in operating income mix from AST to Healthcare.

Posted In: STE